Literature DB >> 2141298

Spectinomycin-resistant gonococci in Thailand.

A Traisupa1, C Ariyarit, S Saengsur, C Theeratum, S Tharavanich.   

Abstract

The incidence of resistance to spectinomycin was determined in 3,200 isolates of Neisseria gonorrhoeae from male and female patients at four venereal disease clinics in Thailand. Susceptibility of the isolates was tested on disks containing 100 micrograms of spectinomycin. There was no evidence of spectinomycin resistance (a zone of inhibition of less than or equal to 18 mm in diameter); the diameter of the inhibitory zone was 19 to 23 mm in 10.9% of the isolates, 24 to 28 mm in 53.7%, 29 to 33 mm in 31.3%, 34 to 38 mm in 4.1%, and 39 mm in 0.05%. The results were similar in the male and female patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2141298

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  4 in total

1.  Antibiotic susceptibility survey of Neisseria gonorrhoeae in Tucumán, Argentina.

Authors:  M C de Castillo; O A de Saab; N P de Fernandez; O M de Nader; A P de Ruiz Holgado
Journal:  Genitourin Med       Date:  1996-04

2.  Antimicrobial susceptibilities of Neisseria gonorrhoeae strains isolated in Surabaya, Indonesia.

Authors:  M R Joesoef; J S Knapp; A Idajadi; M Linnan; Y Barakbah; A Kamboji; P O'Hanley; J S Moran
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

3.  Antibiotic susceptibility survey of Neisseria gonorrhoeae in Thailand.

Authors:  T E Clendennen; P Echeverria; S Saengeur; E S Kees; J W Boslego; F S Wignall
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

4.  The first year of the global Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) in Bangkok, Thailand, 2015-2016.

Authors:  Pachara Sirivongrangson; Natnaree Girdthep; Wichuda Sukwicha; Prisana Buasakul; Jaray Tongtoyai; Emily Weston; John Papp; Teodora Wi; Thitima Cherdtrakulkiat; Eileen F Dunne
Journal:  PLoS One       Date:  2018-11-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.